Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
Clinical trial NCT05871021 · RECRUITING
Trial details
- NCT number
- NCT05871021
- Sponsor
- University Hospital Tuebingen
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2028-04-10
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.